http___www.jeftinoputovanje.com.hr_inter-rail__1.xml
1.1 2.1 3.1 4.1 4.2 4.3 5.1 5.2 5.3 5.4 6.1 6.2 7.1 8.1 9.1 10.1 11.1 12.1 13.1 14.1 15.1 16.1 17.1 18.1 19.1 20.1 20.2 20.3 20.4 20.5
Personal Genetics Leader to Focus on Building DNA-based Community For Women Impacted by Breast Cancer CARLSBAD, Calif., Oct. 2 /PRNewswire/ -- 23andMe, Inc., the industry leader in personal genetics, today announced that it is embarking on a world-wide effort to assemble the largest cohort of women whose lives have been impacted by breast cancer and to build an infrastructure, based on genetics, that will accelerate consumer-based research of the disease. In honor of the 23rd anniversary of October as National Breast Cancer Awareness Month, co-founders Linda Avey and Anne Wojcicki told science and business leaders at Fortune's Most Powerful Women Conference that the company will seek to reach out to, and build a community around, women who have encountered breast cancer, thereby increasing the scientific understanding of the inherited aspects of a disease that affects 200,000 newly diagnosed individuals per year. In recent years, the scientific community has effectively utilized genetic testing to direct and dramatically improve breast cancer treatment. "Great strides have been made in targeting treatment for breast cancer," said Linda Avey. "We'd like to build on this progress, and we believe that by creating a web-based forum that enables women to share their experiences, the entire community could benefit and more personalized treatments may ultimately be an outcome." Women who sign up for 23andMe's genetic testing service can opt-in to take surveys that help drive genome-wide association studies. Genetic profiles combined with medical and family history contribute greatly to research efforts and help researchers understand causes around disease and treatment. The company will be creating a specific breast cancer network within 23andWe, the research division of 23andMe. There, women whose lives have been touched by breast cancer can come together, build a community, share knowledge and offer advice. "Women who have been recently diagnosed with breast cancer can learn a tremendous amount from women who have already been treated," said Anne Wojcicki. "By combining the ability to participate in research with the ability to learn from each other, 23andMe hopes to make a significant contribution to this community." The 23andMe(TM) service enables its customers to: -- Learn how the latest research studies relate to their genomes. -- Actively participate in a new research approach and contribute to the advancement of the field of genetics. -- Compare their profiles to family and friends who are also 23andMe participants and trace the inheritance of genes associated with specific traits. -- Join discussion groups around any areas of interest, both health and ancestry-related. Joining the 23andMe Community To learn more and embark on your own personal genetics journey, please visit: http://www.23andme.com. 23andMe is now available to consumers in the following locations: Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine, the United Kingdom, the United States and Vatican City State. About 23andMe 23andMe, Inc. is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service(TM) enables individuals to gain deeper insights into their ancestry and inherited traits. 23andMe, Inc., was founded by Linda Avey and Anne Wojcicki in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. Its Series A investors include Genentech, Inc., Google Inc. and New Enterprise Associates. More information is available at http://www.23andMe.com.
1.1 2.1 2.2 2.3 2.4 2.5 3.1 3.2 4.1 4.2 4.3 4.4 4.5 5.1 5.2 5.3 5.4 5.5 5.6 6.1 7.1 8.1 9.1 10.1 11.1 12.1 13.1 14.1 14.2 15.1
Inter Rail InterRail karta za putovanje vlakom unutar Europe. Postoje dvije vrste InterRail karti - globalna karta ( "Global Pass"), te karta za svaku zemlju ( "One Country Pass"). "Inflectional" karta dozvoljava slobodno putovanje u određenom broju odabranih dana tijekom razdoblja valjanosti karte. Uz prijevoz vlakom,karte se mogu iskoristiti za prijevoz po posebnim cijenama i popustima koje nude InterRail suradnici prijevoznih poduzeća i dr. (popusti ili besplatni ulazi u muzeje, noćenje po sniženoj cijeni ...). InterRail Pass karta može biti kupljena od osobe s prebivalištem ili boravištem u europskoj zemlji (kao i osobe s privremenim prebivalištem smatra se svatko tko ima dokument kojim se dokazuje da je u Europu došao na više od šest mjeseci).Kupujući karte putnik je dužan znati svoj datum rođenja i mjesto prebivališta (stalno ili privremeno), te imati osobnu iskaznicu, putovnicu ili potvrdu o prebivalištu. Karte su registrirane i ne mogu se prenijeti. Karte se ne primjenjuje u zemlji iz koje dolazi putnika (npr. Hrvatskom držljavanu ne može biti polazna točka Hrvatska nego neki drugi Europski grad). Prilikom kupovine možete kupiti dvije karte sa popustom - jednu za polazak i jedna za povratak - (od mjesta stanovanja do granice ili najbliže zračne luke u zemlji prebivališta.) Visina odobrenog popusta za navedeno putovanje se razlikuje među pojedinačnim željezničkim postajama (među zemljama). Te karte se mogu kupiti samo u zemlji prebivališta. InterRail Pass karte se mogu izdati do tri mjeseca prije prvog dana polaska. InterRail karta ne vrijedi za sve vlakove. U nekim slučajevima će te morati platiti dodatak ili dopunu (required) rezervacija mjesta za korištenje od strane globalne cijene vlakova s obveznom rezervacijom mjesta.Za korištenje kabine sa ležajem u vlaku, ležajeva na brodu u pomorskim kompanijama imaju sezonski doplatak od lipnja do rujna za pomorske rute Superfast Ferries i Blue Star Ferries između Italije i Grčke. Naknadu za obroke u kojoj su uključeni u naknadu za pojedinačne vlakove i druge usluge koje nude vlakovi (npr. novine, telefon ...). Naknada za djelomično korištenje karte nije moguće. U slučaju gubitka ili krađe InterRail karte nije moguć povrat novaca,a nije moguće niti izdati novu kartu. Ako putovanje odkažete prije početka putovanja i vratite ne iskorištenu kartu dobiti će te 80 % novaca natrag. Inter Rail Global Pass Karta Inter Rail Global Pass vrijedi u sljedećih 30 zemalja: Austrija, Belgija, Makedonija, Bosna i Hercegovina, Bugarska, Češka, Crna Gora, Danska, Finska, Francuska, Grčka, Hrvatska, Italija, Irska, Luksemburg, Mađarska, Njemačka, Nizozemska, Norveška, Poljska, Portugal, Rumunjska, Srbija, Slovačka, Slovenija, Španjolska , Švicarska, Švedska, Turska, Velika Britanija i pomorska služba Attica Group , koja vozi na relaciji između Italije i Grčke.InterRail Global Pass karta "kontinuirano" vrijede pod sljedećim rokovima: • 22 dana u roku valjanosti 1 mjesec InterRail Global Pass karte "flexi" vrijede: • 5 dana u roku valjanosti 10 dana • 10 dana u roku valjanosti 22 dana Cijene provjerite ovdje. Inter Rail One Country Pass Putnik ne može kupiti karte InterRail Pass sa sjedištem u zemlji prebivališta. Postoji karta Inter Rail One Country Pass koje se odnose za sljedeće zemlje: Austrija, Belgija, Luksemburg, Nizozemska, Bugarska, Hrvatska, Češka, Danska, Finska, Francuska, Srbija , Makedonija, Njemačka, Velika Britanija, Grčka, Mađarska, Republika Irska, Italija, Norveška, Poljska, Portugal, Rumunjska, Srbija, Slovačka, Slovenija, Španjolska, Švedska, Švicarska, Turskai pomorska služba Attica Group , koja radi na relaciji između Italije i Grčke. Cijene provjerite ovdje.